Sorrento Therapeutics appoints Amar Singh as Chief Business Officer

theflyonthewall.com

Sorrento Therapeutics (SRNE) appointed Amar Singh as Executive VP and Chief Business Officer. In this role, Mr. Singh will be responsible for overseeing Sorrento's partnering activities. Mr. Singh joins Sorrento from Synta Pharmaceuticals (SNTA), where he was a Senior VP and Chief Business Officer.

View Comments